| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 9 |
| 1 | EPOPROSTENOL | 8 |
| 2 | SILDENAFIL CITRATE | 7 |
| 3 | TADALAFIL | 7 |
| 4 | FUROSEMIDE | 6 |
| 5 | MACITENTAN | 6 |
| 6 | ACETAMINOPHEN | 4 |
| 7 | BOSENTAN | 4 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 3 |
| 9 | AMBRISENTAN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 1 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 2 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 3 | CHLORZOXAZONE | 1 | 0.0008 |
| 4 | EPOPROSTENOL | 8 | 0.0006 |
| 5 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 6 | MIDODRINE HYDROCHLORIDE | 2 | 0.0004 |
| 7 | METHYLCELLULOSE | 1 | 0.0004 |
| 8 | PRUCALOPRIDE | 1 | 0.0004 |
| 9 | LEVOCARNITINE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 1 | Antiseptic [EPC] | 1 | 0.0002 |
| 2 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 3 | Prostacycline Vasodilator [EPC] | 16 | 0.0001 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 8 | 0.0001 |
| 8 | Progesterone [EPC] | 1 | 0.0000 |
| 9 | Endothelin Receptor Antagonist [EPC] | 8 | 0.0000 |